**Question:** A screening test becomes more sensitive when,

A. increasing the sample size
B. decreasing the test cut-off point
C. increasing the duration of the test
D. increasing the number of tests performed

**Core Concept:** Sensitivity of a screening test refers to the proportion of truly diseased individuals who test positive. A higher sensitivity is desirable as it ensures that a larger proportion of affected individuals receive appropriate diagnosis and treatment.

**Why the Correct Answer is Right:** When the test cut-off point is decreased (option B), the screening test becomes more sensitive. Lowering the cut-off point means that a higher number of true-positive results (individuals with the disease) will be identified. As a result, the overall sensitivity increases, leading to better detection of diseased individuals.

**Why Each Wrong Option is Incorrect:**

A. Increasing the sample size (option A) does not directly affect test sensitivity. Although a larger sample size may result in more accurate prevalence estimates, it does not necessarily lead to a more sensitive screening test.

B. Decreasing the duration of the test (option C) does not impact test sensitivity. Test duration affects the speed and feasibility of the test, not its ability to detect diseased individuals.

D. Increasing the number of tests performed (option D) does not directly affect test sensitivity. While performing more tests may provide additional data, it does not improve the test's ability to identify diseased individuals.

**Sensitivity and Specificity in Screening Tests:**

Understanding the relationship between sensitivity and specificity is crucial for interpreting screening test results. Sensitivity reflects the test's ability to identify diseased individuals, while specificity represents the test's ability to identify healthy individuals correctly. Ideally, a screening test should be both sensitive and specific to ensure that diseased individuals are detected without also falsely identifying healthy individuals as diseased.

**Clinical Pearls:**

1. A sensitive test is crucial when the prevalence of the disease in the population is low, as it helps identify diseased individuals who may have gone undetected otherwise.
2. Specificity becomes more important when the disease prevalence is high, ensuring that healthy individuals are correctly identified as such and not falsely diagnosed as diseased.
3. In practice, optimal screening tests aim for high sensitivity and specificity values, considering the disease prevalence in the population being tested.

**Correct Answer Explanation:**

When the test cut-off point is decreased (option B), the test becomes more sensitive. This occurs because a lower cut-off point allows a greater number of true-positive results (individuals with the disease) to be identified. Consequently, the overall sensitivity increases, leading to better detection of diseased individuals. However, this may lead to an increase in false-positive results (healthy individuals falsely diagnosed as diseased) as well.

**Clinical Scenario:**

Suppose we are designing a screening test for a disease with a prevalence of 5%. If a test has a sensitivity of 90% and a specificity of 95%, a lower cut-off point would be set to increase sensitivity, potentially reducing specificity. In this scenario, setting a lower